Chromosomal imbalances and NF2 mutational analysis in a series of 10 spinal nerve sheath myxomas.
OBJECTIVE
To report the demographic, clinical and molecular profile of a series of intraspinal nerve sheath myxomas. Nerve sheath myxomas are diagnostically challenging, mainly cutaneous spindle cell neoplasms exhibiting Schwann cell differentiation. They are frequently mistaken for neurothekeomas and their genetic features are essentially unknown.


RESULTS
Ten spinal nerve sheath myxomas with a preferential location in the lumbar spine (70%) were investigated. Presenting symptoms consisted of sciatic pain (100%), muscle weakness and paraesthesia (60% each). Intraoperatively, all tumours were attached to a spinal nerve. Chromosomal imbalances by comparative genomic hybridization were found in 8/10 cases, consisting of -22q (80%) and -19 (30%). Polymerase chain reaction analysis of the NF2 gene (exons 1-16) revealed two tumours with mutations in exon 8 and 14, respectively.


CONCLUSIONS
Although these 10 nerve sheath myxomas exhibited Schwann cell differentiation and frequently showed loss of chromosome 22q typically encountered in peripheral nerve tumours, only two cases demonstrated mutations of the NF2 gene. This may indicate involvement of other tumour suppressor genes on 22q in nerve sheath myxomas and shows that they are more closely related at the molecular level to sporadic schwannomas, underscoring the presumption that they are true nerve sheath tumours.
Rickert
C H
CH
Institute of Neuropathology, University Hospital Münster, Münster, Germany. christian.rickert@rch.org.au
Schwering
E-M
EM
Siebers
J
J
Hartmann
C
C
von Deimling
A
A
Paulus
W
W
D000328:Adult; D000368:Aged; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D025581:Neurofibromin 2 / Q000235:genetics*; D018321:Neurothekeoma / Q000235:genetics* / Q000473:pathology; D013127:Spinal Nerves / Q000473:pathology*
D025581:Neurofibromin 2